It’s officially prime time for chemical engineering majors.
Dow Chemical Company just announced that it will pour 125 million into Chemical Engineering programs at 11 US Universities to garner top students currently entering faster growing fields, like biomedical engineering.
According to a report by the Wall Street Journal, over the last decade biomedical engineering undergrads tripled at 3,670 per year, while undergrad degrees in chemical engineering remained flat.
Overall, the investment will (hopefully) spur more engineering degrees in every sector and for all degree levels. For instance, from 1990 to 2010 doctorates in engineering rose 50% to about 9,000—a number that still falls short of satisfying demand when compared internationally.
Personally, I think only good things can come out of the investment by Dow Chemical Company, and if you’re considering entering the chemical engineering field, look into the lucky schools on the receiving end of this generous endeavor: the California Institute of Technology; Carnegie Mellon; the Georgia Institute of Technology; Northwestern; Pennsylvania State; the University of California’s Berkeley and Santa Barbara campuses, and the Universities of Illinois at Urbana-Champaign, Michigan, Minnesota, and Wisconsin.
No related posts.